View in EDS HTML Full Text PDF Full Text

Assessing the Safety and Efficacy of Lamotrigine as Anti-myotonic Agent in Myotonic Dystrophy Type 1 (DM1): A Longitudinal, Open-Label, Pilot Study.

Saved in:
Bibliographic Details
Title: Assessing the Safety and Efficacy of Lamotrigine as Anti-myotonic Agent in Myotonic Dystrophy Type 1 (DM1): A Longitudinal, Open-Label, Pilot Study.
Authors: Risi, Barbara1,2 (AUTHOR), Ait Allali, Nesaiba1 (AUTHOR), Cotti Piccinelli, Stefano1 (AUTHOR), Caria, Filomena1 (AUTHOR), Damioli, Simona1 (AUTHOR), Labella, Beatrice3,4 (AUTHOR), Bertella, Enrica1 (AUTHOR), Giovanelli, Giorgia1 (AUTHOR), Garofali, Francesca1 (AUTHOR), Margollicci, Giuseppina1 (AUTHOR), Carugati, Roberto1 (AUTHOR), Ferullo, Lucia3,4 (AUTHOR), Olivieri, Emanuele3,4 (AUTHOR), Poli, Loris3 (AUTHOR), Padovani, Alessandro3,4 (AUTHOR), Filosto, Massimiliano1,4 (AUTHOR) massimiliano.filosto@unibs.it
Source: Neurology & Therapy. Oct2025, Vol. 14 Issue 5, p2249-2260. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21938253
DOI:10.1007/s40120-025-00804-z